G. Stehle

Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer

Ralf‐Dieter Hofheinz, Salah‐Eddin Al‐Batran, Frank Hartmann et al. · Oncology Research and Treatment · 2003 · 366 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Albumin-Based Drug Delivery as Novel Therapeutic Approach for Rheumatoid Arthritis

Andreas Wunder, Ulf Müller‐Ladner, Ernst H. K. Stelzer et al. · The Journal of Immunology · 2003 · 221 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.

Pontus K.E. Börjesson, Ernst J. Postema, Jan C. Roos et al. · PubMed · 2003 · 114 citations

Pharmacy, Oncology, Radiation Oncology +17

The loading rate determines tumor targeting properties of methotrexate albumin conjugates in rats

G. Stehle, H. Sinn, Andreas Wunder et al. · Anti-Cancer Drugs · 1997 · 103 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.

G. Hartung, G. Stehle, H. Sinn et al. · PubMed · 1999 · 89 citations

Medicine, Oncology, Pharmacology +16